Effect of Co-Administration of Retinoids on Rat Embryo Development In Vitro

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 6, 2003, Pages 444-451

  Ritchie, Helen E ^a   Brown Woodman, Patricia D ^a   Korabelnikoff, Ann ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 OXORETINOIC ACID; ALITRETINOIN; RETINOIC ACID; RETINOID; RETINOL; RETINOL PALMITATE;

ANIMAL TISSUE; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG POTENTIATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; FEMALE; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; EMBRYO; FEMALE; ORGAN CULTURE TECHNIQUES; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RETINOIDS; TERATOGENS;

MAMMALIA;

EID: 1242337274     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10054     Document Type: Article

References (55)

1. Arafa HMM, Elmazar MMA, Hamada FMA, Reichert U, Shroof B, Nau H. 2000. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure. Arch Toxicol 73:547-556.
2. Arnhold T, Tzimas G, Wittfoht W, Plonait S, Nau H. 1996. Identification of 9-cis-retinoic acid, 9,13-d-cis-retinioc acid, and 14-hydroxy-4,14-retroretinol in human plasma after liver consumption. Life Sci 59:169-177.
3. Blumberg B, Bolado J Jr, Derguini F, Craig AG, Moreno TA, Chakravarti D, Heyman RA, Buck J, Evans RM. 1996. Novel retinoic acid receptor ligands in Xenopus embryos. Proc Natl Acad Sci USA 93:4873-4878.
4. Brown NA, Fabro S. 1981. Quantitation of rat embryonic development in vitro: A morphological scoring system. Teratology 24:65-78.
5. Buss NE, Tembe BD, Prendergast BD, Renwick AG, George CF. 1994. The teratogenic metabolites of vitamin A in women following supplements and liver. Hum Exp Toxicol 13:333-343.
6. Chen H, Yang HY, Namkung MJ, Juchau MR. 1996a. Interactive dysmorphogenic effects of all-trans-retinol and ethanol on cultured whole rat embryos during organogenesis. Teratology 54:12-19.
7. Chen C, Mistry G, Jensen B, Heizmann P, Timm U, van Brummelen P, Rakhit AK. 1996b. Pharmacokinetics of retinoids in women after meal consumption or vitamin A supplementation. J Clin Pharm 36:799-808.
8. Cohlan S. 1953. Excessive intake of retinoid as a cause of congenital anomalies in the rat. Science 117:535-536.
9. Cohlan S. 1954. Congenital anomalies in the rat produced by excessive intake of retinoid during pregnancy. Pediatrics 13:556.
10. Collins M, Tzimas G, Hummler H, Burgin H, Nau H. 1994. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administration in rats. Toxicol Appl Pharmacol 127:132-144.
11. Creech Kraft J, Juchau M. 1993. 9-cis-retinoic acid is a direct-acting dysmorphogen. Teratology 47:385.
12. Eckhoff C, Collins M, Nau H. 1991. Human plasma all-trans-,13-cis- and 13-cis-4oxoretinoic acid during subchronic vitamin A supplementation: comparison to retinol and retinyl ester plasma levels. J Nutr 121:1016-1025.
13. Eckhoff C, Nau H. 1990. Identification and quantitation of all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma. J Lipid Res 31:1445-1454.
14. Geelen JAG. 1979. Hypervitaminosis A induced teratogenesis. CRC Cr Rev Tox 6:351-376.
15. Giroud A, Martinet M. 1959. Teratogenese par hypervitaminose A chez le rat, la souris, le cobaye et le lapin. Arch Fr Pediatr 16:971.
16. Grummer MA, Zachman RD. 2000. Interaction of ethanol with retinol and retinoic acid in RAR beta and GAP-43 expression. Neurotoxicol Teratol 22:829-836.
17. Haghdoost NR, Newman LM, Johnson EM. 1997. Multiple chemical exposures: synergism vs. individual exposure levels. Reprod Toxicol 11:9-27.
18. Hamish DC, Barua AB, Soprano KI, Soprano DR. 1990. Induction of β-retinoic acid receptor mRNA by teratogenic doses of retinoids in murine fetuses. Differentiation 45:103-108.
19. Hathcock JN, Hattan DG, Jenkins MY, McDonald JT, Sundaresan PR, Wilkening VL. 1990. Evaluation of vitamin A toxicity. Am J Clin Nutr 52:183-202.
20. Kalter H, Warkany J. 1961. Experimental production of congenital malformations in strains of inbred mice by maternal treatment with hypervitaminosis A. Am J Pathol 38:1-21.
21. Kalter H. 1959. Teratogenic action of hypervitaminosis A in strains of inbred mice. Anat Rec 133:396-397.
22. Kamm JJ. 1982. Toxicology, carcinogenicity and teratogenicity of some orally administered retinoids. J Am Acad Dermatol 6:652-659.
23. Kochhar DM, Penner JD, Satre MA. 1988. Derivation of retinoic acid and metabolites from a teratogenic dose of retinol (vitamin A) in mice. Toxicol Appl Pharmacol 96:429-441.
24. La Vista-Picard N, Hobbs PD, Pfahl M, Dawson MI, Pfahl M. 1996. The receptor-DNA complex determines the retinoid response: a mechanism for the diversification of the ligand signal. Mol Cell Biol 16:4137-4146.
25. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Bencke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW Jr, Lott IT, Richard JM, Sun SC. 1985. Retinoic acid embryopathy. N Engl J Med 313:837-841.
26. Langman J, Welch GW. 1966. Effect of retinoid on development of the central nervous system. J Comp Neurol 128:1-16.
27. Love A, Vickers T. 1971. Hypervitaminosis A dysmelia in rats. Br J Exp Pathol 52:656-668.
28. Marin-Padilla M, Ferm V. 1965. Somite necrosis and developmental malformations induced by retinoid in the golden hamster. J Embryol Exp Morphol 13:1-8.
29. Martinez-Frias ML, Salvador J. 1990. Epidemiological aspects of prenatal exposure to high doses of vitamin A in Spain. Eur J Epidemiol 6:118-123.
30. Mastroiacovo P, Mazzone T, Addis A, Elephant E, Carlier P, Vial T, Garbis H, Robert E, Bonati M, Ornoy A, Finardi A, Schaffer C, Caramelli L, Rodríguez-Pinilla E, Clementi M. 1999. High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. Teratology 59:7-11
31. Mathews L, Johnson E, Newman L. 1981. Introduction of late gestational teratogenesis in rat lung by hypervitaminosis A. Teratology 22:253-258.
32. McCaffery P, Drager UC. 2000. Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor. Cytokine Growth Factor Rev 11:233-249.
33. Miller RK, Hendrickx AG, Mills JL, Hummler H, Wiegand UW. 1998. Periconceptional vitamin A use: how much is teratogenic? Reprod Toxicol 12:75-88.
34. Minucci S, Leid M, Toyama R, Saint-Jeannet JP, Peterson VJ, Horn V, Ishmael JE, Bhattacharyya N, Dey A, Dawid IB, Ozato K. 1997. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression. Mol Cell Biol 17:644-655.
35. Morriss G, Steele C. 1974. The effect of excess retinoid on the development of rat embryos in culture. J Embryol Exp Morphol 32:505-514.
36. Morriss-Kay GM, Ward SJ. 1999. Retinoids and mammalian development. Int Rev Cytol 188:73-131.
37. Napoli JL. 1993. Biosynthesis and metabolism of retinoic acid: roles of CRBP and CRABP in retinoic acid homeostasis. J Nutr 123:362-366.
38. National Heart Foundation. 1986. National Dietary survey of adults: 1983. Department of Community Services, Australian Government Publishing Service, Canberra.
39. Nelson BK. 1994. Interactions in developmental toxicology: a literature review and terminology proposal. Teratology 49:33-71.
40. New DAT. 1973. Whole-embryo culture and the study of mammalian embryos during embryogenesis. Biol Rev 53:81-122.
41. Niederreither K, Abu-Abed S, Schuhbaur B, Petkovich M, Chambon P, Dolle P. 2002. Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development. Nat Gen 31:84-88.
42. Repa JJ, Hanson KK, Clagett-Dame M. 1993. All-trans-retinol is a ligand for the retinoic acid receptors. Proc Natl Acad Sci USA 90:7293-7297.
43. Ritchie H, Webster WS. 1991. Parameters determining isotretinoin teratogenicity in rat embryo culture. Teratology 43:71-81.
44. Ritchie HE, Webster WS, Eckhoff C, Oakes DJ. 1998. Model predicting the teratogenic potential of retinyl palmitate, using a combined in vivo/in vitro approach. Teratology 58:113-123.
45. Robens J. 1970. Teratogenic effects of hypervitaminosis A in the hamster and guinea pig. Toxicol Appl Pharmacol 16:88-99.
46. Rosa FW, Wilk A, Kelsey FO. 1986. Teratogen update: vitamin A congeners. Teratology 33:355-364.
47. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. 1995. Teratogenicity of high vitamin A intake. N Engl J Med 333:1369-1373.
48. Roy B, Taneja R, Chambon P. 1995. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR α)-, RAR β-, or RAR γ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol Cell Biol 15:6481-6487.
49. Ruberte E, Dolle P, Chambon P, Morriss-Kay G. 1991. Retinoic acid receptors and cellular retinoid binding proteins. II. Their differential pattern of transcription during early morphogenesis in mouse embryos. Development 111:45-60.
50. Shenefelt R. 1972. Morphogenesis of malformations in hamsters caused by retinoic acid: relation to dose and stage at treatment. Teratology 5:103-118.
51. Singh S, Padmanabahn R, Singh G, Kaur G. 1983. Effect of maternal hypervitaminosis A during late gestation of pre- and postnatal lung maturation in rat. Indian J Exp Biol 21:103-107.
52. Swindell EC, Thaller C, Sockanathan S, Petkovich M, Jessell TM, Eichele G. 1999. Complementary domains of retmoic acid production and degradation in the early chick embryo. Dev Biol 216:282-296.
53. Tang G, Russell R. 1991. Formation of all-trans-retinoic acid and 13-cis-retinoic acid from all-trans-retinyl palmitate in humans. J Nutr Biochem 2:210-213.
54. Tembe EA, Honeywell R, Buss NE, Renwick AG. 1996. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits. Toxicol Appl Pharmacol 141:456-472.
55. Webster WS, Johnston MC, Lammer EJ, Sulik KK. 1986. Isotretinoin embryopathy and the cranial neural crest: an in vivo and in vitro study. J Craniofac Genet Dev Biol 6:211-222.